These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
638 related items for PubMed ID: 27178807
1. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo. Zhu Y, Zhang J, Meng F, Deng C, Cheng R, Feijen J, Zhong Z. J Control Release; 2016 Jul 10; 233():29-38. PubMed ID: 27178807 [Abstract] [Full Text] [Related]
2. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y, Jiang Y, Zou Y, Meng F, Zhang J, Deng C, Sun H, Zhong Z. Acta Biomater; 2017 Mar 01; 50():396-406. PubMed ID: 28065871 [Abstract] [Full Text] [Related]
3. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Zhong Y, Yang W, Sun H, Cheng R, Meng F, Deng C, Zhong Z. Biomacromolecules; 2013 Oct 14; 14(10):3723-30. PubMed ID: 23998942 [Abstract] [Full Text] [Related]
4. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. Zhong Y, Wang C, Cheng R, Cheng L, Meng F, Liu Z, Zhong Z. J Control Release; 2014 Dec 10; 195():63-71. PubMed ID: 25108151 [Abstract] [Full Text] [Related]
5. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo. Gu X, Wei Y, Fan Q, Sun H, Cheng R, Zhong Z, Deng C. J Control Release; 2019 May 10; 301():110-118. PubMed ID: 30898610 [Abstract] [Full Text] [Related]
6. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy. Zou Y, Fang Y, Meng H, Meng F, Deng C, Zhang J, Zhong Z. J Control Release; 2016 Dec 28; 244(Pt B):326-335. PubMed ID: 27245309 [Abstract] [Full Text] [Related]
7. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Sun H, Guo B, Cheng R, Meng F, Liu H, Zhong Z. Biomaterials; 2009 Oct 28; 30(31):6358-66. PubMed ID: 19666191 [Abstract] [Full Text] [Related]
8. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Sun H, Guo B, Li X, Cheng R, Meng F, Liu H, Zhong Z. Biomacromolecules; 2010 Apr 12; 11(4):848-54. PubMed ID: 20205476 [Abstract] [Full Text] [Related]
9. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Chen W, Zhong P, Meng F, Cheng R, Deng C, Feijen J, Zhong Z. J Control Release; 2013 Aug 10; 169(3):171-9. PubMed ID: 23306022 [Abstract] [Full Text] [Related]
10. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo. Qiu M, Sun H, Meng F, Cheng R, Zhang J, Deng C, Zhong Z. J Control Release; 2018 Feb 28; 272():107-113. PubMed ID: 29355618 [Abstract] [Full Text] [Related]
11. cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo. Zhu Y, Zhang J, Meng F, Deng C, Cheng R, Feijen J, Zhong Z. ACS Appl Mater Interfaces; 2017 Oct 18; 9(41):35651-35663. PubMed ID: 28952305 [Abstract] [Full Text] [Related]
12. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release. Cui C, Yu P, Wu M, Zhang Y, Liu L, Wu B, Wang CX, Zhuo RX, Huang SW. Colloids Surf B Biointerfaces; 2015 May 01; 129():137-45. PubMed ID: 25843367 [Abstract] [Full Text] [Related]
13. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P, Liu J, Wang W, Zhang Y, Zhao F, Kong D, Liu J, Dong A. Acta Biomater; 2016 Aug 01; 40():263-272. PubMed ID: 26607767 [Abstract] [Full Text] [Related]
14. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release. Chen W, Meng F, Cheng R, Deng C, Feijen J, Zhong Z. J Control Release; 2015 Jul 28; 210():125-33. PubMed ID: 25987525 [Abstract] [Full Text] [Related]
15. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma. Yin X, Feng S, Chi Y, Liu J, Sun K, Guo C, Wu Z. Drug Deliv; 2018 Nov 28; 25(1):900-908. PubMed ID: 29644882 [Abstract] [Full Text] [Related]
16. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs. Chen W, Zou Y, Meng F, Cheng R, Deng C, Feijen J, Zhong Z. Biomacromolecules; 2014 Mar 10; 15(3):900-7. PubMed ID: 24460130 [Abstract] [Full Text] [Related]
17. αvβ3 Integrin-targeted reduction-sensitive micellar mertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivo. Zhong P, Meng H, Qiu J, Zhang J, Sun H, Cheng R, Zhong Z. J Control Release; 2017 Aug 10; 259():176-186. PubMed ID: 27986551 [Abstract] [Full Text] [Related]
18. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo. Chen W, Zou Y, Zhong Z, Haag R. Small; 2017 Feb 10; 13(6):. PubMed ID: 27865044 [Abstract] [Full Text] [Related]
19. Construction of Small-Sized, Robust, and Reduction-Responsive Polypeptide Micelles for High Loading and Targeted Delivery of Chemotherapeutics. Xue S, Gu X, Zhang J, Sun H, Deng C, Zhong Z. Biomacromolecules; 2018 Aug 13; 19(8):3586-3593. PubMed ID: 30025206 [Abstract] [Full Text] [Related]
20. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Xiao K, Luo J, Li Y, Lee JS, Fung G, Lam KS. J Control Release; 2011 Oct 30; 155(2):272-81. PubMed ID: 21787818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]